| Accession Number | 0002013623-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 2,437 | $8.26 | $20,129.62 | 2,437 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 2,438 | $8.26 | $20,137.88 | 4,875 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Sale | 2,437 | $15.00 | $36,555.00 | 2,438 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 30, 2026 | Sale | 2,438 | $15.02 | $36,611.93 | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 2,437 | $0.00 | $0.00 | 78,001 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 2,438 | $0.00 | $0.00 | 75,563 | Direct | โ | View Details |